Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Transcription profiling of lung and liver from low and high dose Perfluorooctanoic Acid exposed fetuses


ABSTRACT: Exposure to PFOA during gestation altered the expression of genes related to fatty acid catabolism in both the fetal liver and lung. In the fetal liver, the effects of PFOA were robust and also included genes associated with lipid transport, ketogenesis, glucose metabolism, lipoprotein metabolism, cholesterol biosynthesis, steroid metabolism, bile acid biosynthesis, phospholipid metabolism, retinol metabolism, proteosome activation, and inflammation. These changes are consistent with activation of PPAR alpha. Non-PPAR alpha related changes were suggested as well. Experiment Overall Design: Experiment 1: High Dose: Thirty timed-pregnant CD-1 mice were orally dosed from gestation day 1-17 with either 0, 5, or 10 mg/kg/day PFOA in water. At term, fetal lung and liver were collected, total RNA prepared, and samples pooled from three fetuses per litter. Five biological replicates consisting of individual litter samples were then evaluated for treatment group using Affymetrix mouse 430_2 microarrays. Experiment Overall Design: Experiment 2: Low Dose: Thirty timed-pregnant CD-1 mice were orally dosed from gestation day 1-17 with either 0, 1, or 3 mg/kg/day PFOA in water. At term, fetal lung and liver were collected, total RNA prepared, and samples pooled from three fetuses per litter. Five biological replicates consisting of individual litter samples were then evaluated for treatment group using Affymetrix mouse 430_2 microarrays (note one microarray from the lung + 1mg/kg/day dose group was excluded from the study due to high background). Experiment Overall Design: Please note that each dose experiment had separate concurrent controls.

ORGANISM(S): Mus musculus

SUBMITTER: Mitchell Rosen 

PROVIDER: E-GEOD-13044 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Gene expression profiling in the lung and liver of PFOA-exposed mouse fetuses.

Rosen Mitchell B MB   Thibodeaux Julie R JR   Wood Carmen R CR   Zehr Robert D RD   Schmid Judith E JE   Lau Christopher C  

Toxicology 20070629 1-2


Perfluorooctanoic acid (PFOA) is a stable perfluoroalkyl acid used to synthesize fluoropolymers during the manufacture of a wide variety of products. Concerns have been raised over the potential health effects of PFOA because it is persistent in the environment and can be detected in blood and other tissues of many animal species, including humans. PFOA has also been shown to induce growth deficits and mortality in murine neonates. To better understand the mechanism of PFOA induced developmental  ...[more]

Similar Datasets

2009-05-16 | E-GEOD-13302 | biostudies-arrayexpress
2008-05-22 | E-GEOD-9796 | biostudies-arrayexpress
2008-10-07 | GSE13044 | GEO
2022-09-02 | GSE212294 | GEO
2015-01-26 | GSE51970 | GEO
2019-12-15 | GSE128824 | GEO
2022-02-17 | PXD027486 | Pride
2014-08-05 | E-GEOD-51664 | biostudies-arrayexpress
2015-01-26 | E-GEOD-51970 | biostudies-arrayexpress
2021-03-25 | PXD014619 | Pride